See the DrugPatentWatch profile for exparel
The cost of EXPAREL can vary significantly, with average retail prices ranging from approximately $1,200 to $1,500 for a 20 mL vial. This price can differ based on the pharmacy, location, and insurance coverage.
What factors influence EXPAREL's price?
Several elements contribute to the final cost of EXPAREL for patients. These include the specific dosage administered, the healthcare setting where it is provided (e.g., hospital, outpatient clinic), and any negotiated discounts or rebates. Insurance plans also play a crucial role, with out-of-pocket expenses often determined by co-pays, deductibles, and coinsurance. For those without insurance or with high-deductible plans, the full retail price is typically applicable.
How can I find out the exact cost for my procedure?
To determine the precise cost of EXPAREL for a specific medical procedure, it is recommended to consult directly with your healthcare provider or the hospital/clinic where the procedure will take place. They can provide a detailed estimate based on your treatment plan and insurance information. You can also inquire about patient assistance programs that might be available to help reduce out-of-pocket expenses.
Are there financial assistance programs for EXPAREL?
Yes, financial assistance options may be available for patients who need EXPAREL. These programs are often designed to help offset the cost for eligible individuals who have commercial insurance and face high out-of-pocket expenses. Details about these programs can typically be found through the drug manufacturer's website or by asking your healthcare provider.
How does EXPAREL pricing compare to other pain management options?
EXPAREL, a non-opioid pain medication delivered via injection, offers extended pain relief. Its cost should be considered in the context of the overall treatment plan, which may include other pain management strategies. While initial upfront costs for EXPAREL might be higher than some short-acting pain relievers, its prolonged effect can potentially reduce the need for multiple administrations of other medications and associated healthcare visits over time. A comprehensive cost-benefit analysis would compare EXPAREL's price and duration of action against the cumulative costs of alternative pain management approaches.
When does EXPAREL's patent protection expire?
Information on the patent expiry of EXPAREL is available through resources that track drug patents. Patents for pharmaceuticals provide a period of market exclusivity. Once patents expire, generic or biosimilar versions of the drug may become available, potentially leading to lower prices. For detailed and up-to-date information on EXPAREL's patent status, DrugPatentWatch.com can be a valuable resource [1].
Can generic versions of EXPAREL become available?
The availability of generic versions of EXPAREL depends on the expiration of its relevant patents and any other forms of market exclusivity. If patents expire without further legal extensions or protections, the U.S. Food and Drug Administration (FDA) can approve generic versions. These generic alternatives, when available, typically offer a more affordable option for consumers. Information regarding patent expirations and the potential for generic entry can be found on specialized patent tracking websites like DrugPatentWatch.com [1].
What is EXPAREL used for?
EXPAREL (bupivacaine liposome injectable suspension) is a long-acting local anesthetic used to manage moderate to severe pain at the surgical site. It is administered by a healthcare professional during surgery to provide pain relief for an extended period after the procedure, potentially reducing the need for opioid pain medications. It is approved for various surgical procedures, including those of the foot and ankle, knee, hip, and abdomen.